Open for inclusion

A Phase 1b Study to Evaluate safety and clinical activity of Pembrolizumab (MK-3475) in combination with Chemotherapy as Neoadjuvant Treatment for Triple Negative Breast Cancer (TNBC) – (KEYNOTE 173)

Cancer type: Breast cancer

Phase: I

Principal Investigator: Foukakis Theodoros

Country: SE

Keywords: Sweden, Karolinska, TNBC, Neoadjuvant, Pembrolizumab

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02622074?term=A+Phase+1b+Study+to+Evaluate+safety+and+clinical+activity+of+Pembrolizumab+%28MK-3475%29+in&rank=1